Galectin Therapeutics Inc

Galectin Therapeutics Inc (GALT)’s latest performance is not what we had anticipated
Zack King
On Friday, Galectin Therapeutics Inc (NASDAQ: GALT) was -8.89% drop from the session before settling in for the closing price ...

Now that Galectin Therapeutics Inc’s volume has hit 0.5 million, investors get a glimpse of its size.
Zack King
On Friday, Galectin Therapeutics Inc (NASDAQ: GALT) was -6.81% drop from the session before settling in for the closing price ...





